Thompson Davis & Co., Inc. Biote Corp. Transaction History
Thompson Davis & Co., Inc.
- $153 Million
- Q4 2024
A detailed history of Thompson Davis & Co., Inc. transactions in Biote Corp. stock. As of the latest transaction made, Thompson Davis & Co., Inc. holds 12,450 shares of BTMD stock, worth $63,121. This represents 0.05% of its overall portfolio holdings.
Number of Shares
12,450Holding current value
$63,121% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding BTMD
# of Institutions
84Shares Held
17.8MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY4.55MShares$23.1 Million13.05% of portfolio
-
Bandera Partners LLC New York, NY2.44MShares$12.3 Million5.13% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$8.14 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$7.19 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.39MShares$7.06 Million0.04% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $38.4M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...